L & L Bio Co., Ltd., Ningbo, China
Clinical trials sponsored by L & L Bio Co., Ltd., Ningbo, China, explained in plain language.
-
New drug combo aims to control advanced cancers
Disease control Recruiting nowThis study tests two experimental drugs (LB1410 and LB4330) given together to people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if the combination is safe and can shrink or control tumors. About 194 adults will take…
Phase: PHASE1, PHASE2 • Sponsor: L & L Bio Co., Ltd., Ningbo, China • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New Dual-Action antibody takes on advanced cancers in early trial
Disease control Recruiting nowThis early-stage study tests an experimental drug called LB1410 in people with advanced solid tumors or lymphoma that hasn't responded to standard treatments. The drug is a bispecific antibody designed to target two immune checkpoints (PD-1 and TIM-3) to help the immune system fi…
Phase: PHASE1 • Sponsor: L & L Bio Co., Ltd., Ningbo, China • Aim: Disease control
Last updated May 18, 2026 12:02 UTC